Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It's painful to watch the stock getting hammered due to no fault of its own. All the financial markets are brutally in the red today. The Dow plummeting $1,281.44, Nasdaq down $761.04, & the S&P 500 down $181.49. Ouch!
I think it has more to do with financial markets repeatedly bleeding red, double-digit inflation, high gas prices, & etc. The entire biotech market has been getting hammered...not just Avit.
Don't forget that there's an Oramed presentation in about an hour.
https://lifesci.rampard.com/WebcastingAppv5/Events/Registration/registration.jsp?Y2lk=MTcxOQ==&Y2lk=MTcxOQ==&Y2lk=MTcxOQ==
@ 18:37, Perry mentions that they anticipate FDA submission of the PMA in the second half of this year for vitiligo.
@ 20:29, Perry mentions that they anticipate FDA submission of the PMA in the second half of this year for soft tissue reconstruction with approval in the second half of next year.
We're supposed to get some news about the phase 3 trials and the covid trial this summer.
This Zoom webinar will start @ 7pm central time, approximately 90 minutes from now.
I Am ALS is nearly at their petition goal of 45,000. Currently, they are @ 43,152. If you have not signed yet, here is the link:
https://iamals.org/action/brainstorm-fda-petition/
AVITA invites you to attend its investor presentation.
Time: Mar 24, 2022 11:00 AM
https://zoom.us/webinar/register/WN_LgAAB_tyQGS6vyEPG1yAgw
H.C. Wainwright Thinks Oramed Pharmaceuticals’ Stock is Going to Recover
https://www.tipranks.com/news/blurbs/h-c-wainwright-thinks-oramed-pharmaceuticals-stock-is-going-to-recover?mod=mw_quote_news
ALS clinical trials: How stem cells could fuel biomarker development
BrainStorm Cell Therapeutics is generating stem cells to test its ALS drug in a genetic subpopulation after missing the mark in a Phase III trial.
https://www.clinicaltrialsarena.com/news/als-stem-cells-brainstorm/
Barclay presentation just started.
Oramed to Present at Barclays Global Healthcare Conference
Cowen Conference Presentation:
https://hotcopper.com.au/documentembed?id=uOMxKKzFkiWRTLKhOROKAxjvSTYP6we%2FzxaZoeFxke92GA%3D%3D
It's up 4.82% in after hours trading from the news. One more percent and it will erase today's loss.
Avita Medical, Inc. Signs Agreement with Premier, Inc. to Supply the RECELL® System to Hospitals and Health Systems Across the U.S.
Avita Medical, Inc. Signs Agreement with Premier, Inc. to Supply the RECELL® System to Hospitals and Health Systems Across the U.S.
Interesting post from the No More Excuses facebook page:
The Aussie stock closed up 25.68% tonight. I'm really curious what the stock will do tomorrow at the morning bell.
The Aussie stock is up 21% so far tonight.
Yup...up 6.89% in after hours trading. Curious to see what will happen at the morning bell tomorrow.
The RECELL® System Receives PMDA Approval in Japan and AVITA Medical will Commercialize in Partnership with COSMOTEC, an M3 Group Company
https://seekingalpha.com/pr/18683803-recell-system-receives-pmda-approval-in-japan-and-avita-medical-will-commercialize-in
Brainstorm Cell Therapeutics Announces Grant of a New Brazilian Patent Covering Methods of Manufacturing NurOwn
https://ir.brainstorm-cell.com/2022-02-15-Brainstorm-Cell-Therapeutics-Announces-Grant-of-a-New-Brazilian-Patent-Covering-Methods-of-Manufacturing-NurOwn-R
Hopefully, that news will get the stock to push up tomorrow. Too bad that all the financial markets got hammered today.
Avita announced today that it plans to release its July 1, 2021 to December 31, 2021 financial results after the market closes on Monday, February 28, 2022. In conjunction with such release, the Company plans to host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time (Tuesday, March 1, 2022 at 8:30 a.m. Australian Eastern Daylight Time) to discuss its financial results and recent highlights.
Dr. Robert Califf is the new FDA Commissioner.
I read this on the No More Excuses! ALS Watchdog Group on Facebook:
the company's estimated earnings date is Thursday, February 10th, 2022 based off prior year's report dates.
Quick question:
Since the ACT for ALS passed, does this mean that patients will be able to get access to Nurown to treat their MS? I don't think the bill lets ALS patients access Nurown since the FDA did not pass their phase 3 trials but Nurown did pass their phase 2 trials for MS and is still in play with an upcoming phase 3 trial.